{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:41:02Z","timestamp":1767181262097,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1010109","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000}}],"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"USDA","doi-asserted-by":"crossref","award":["ILLU-971-344"],"award-info":[{"award-number":["ILLU-971-344"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000199","name":"USDA","doi-asserted-by":"crossref","award":["ILLU-698-369"],"award-info":[{"award-number":["ILLU-698-369"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012211","name":"Carle Foundation Hospital","doi-asserted-by":"publisher","award":["C*Star"],"award-info":[{"award-number":["C*Star"]}],"id":[{"id":"10.13039\/100012211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005302","name":"University of Illinois at Urbana-Champaign","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005302","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Heterogeneity of cancer means many tumorigenic genes are only aberrantly expressed in a subset of patients and thus follow a bimodal distribution, having two modes of expression within a single population. Traditional statistical techniques that compare sample means between cancer patients and healthy controls fail to detect bimodally expressed genes. We utilize a mixture modeling approach to identify bimodal microRNA (miRNA) across cancers, find consistent sources of heterogeneity, and identify potential oncogenic miRNA that may be used to guide personalized therapies. Pathway analysis was conducted using target genes of the bimodal miRNA to identify potential functional implications in cancer.\n                    <jats:italic>In vivo<\/jats:italic>\n                    overexpression experiments were conducted to elucidate the clinical importance of bimodal miRNA in chemotherapy treatments. In nine types of cancer, tumors consistently displayed greater bimodality than normal tissue. Specifically, in liver and lung cancers, high expression of miR-105 and miR-767 was indicative of poor prognosis. Functional pathway analysis identified target genes of miR-105 and miR-767 enriched in the phosphoinositide-3-kinase (PI3K) pathway, and analysis of over 200 cancer drugs\n                    <jats:italic>in vitro<\/jats:italic>\n                    showed that drugs targeting the same pathway had greater efficacy in cell lines with high miR-105 and miR-767 levels. Overexpression of the two miRNA facilitated response to PI3K inhibitor treatment. We demonstrate that while cancer is marked by considerable genetic heterogeneity, there is between-cancer concordance regarding the particular miRNA that are more variable. Bimodal miRNA are ideal biomarkers that can be used to stratify patients for prognosis and drug response in certain types of cancer.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1010109","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:39:07Z","timestamp":1654004347000},"page":"e1010109","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genome-wide cross-cancer analysis illustrates the critical role of bimodal miRNA in patient survival and drug responses to PI3K inhibitors"],"prefix":"10.1371","volume":"18","author":[{"given":"Laura","family":"Moody","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-1962","authenticated-orcid":true,"given":"Guanying Bianca","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3219-4367","authenticated-orcid":true,"given":"Yuan-Xiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8764-0024","authenticated-orcid":true,"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"issue":"5","key":"pcbi.1010109.ref001","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"issue":"12 Suppl","key":"pcbi.1010109.ref002","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U","article-title":"The value of estrogen and progesterone receptors in the treatment of breast cancer","volume":"46","author":"CK Osborne","year":"1980","journal-title":"Cancer"},{"issue":"21","key":"pcbi.1010109.ref003","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update","volume":"32","author":"HJ Burstein","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"pcbi.1010109.ref004","first-page":"52","article-title":"Breast cancer statistics, 2013","volume":"64","author":"C DeSantis","year":"2014","journal-title":"CA: a cancer journal for clinicians"},{"issue":"10","key":"pcbi.1010109.ref005","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/bioinformatics\/btu039","article-title":"The most informative spacing test effectively discovers biologically relevant outliers or multiple modes in expression","volume":"30","author":"I Pawlikowska","year":"2014","journal-title":"Bioinformatics"},{"key":"pcbi.1010109.ref006","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-12-43","article-title":"MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms","volume":"12","author":"M Affara","year":"2011","journal-title":"Bmc Genomics"},{"key":"pcbi.1010109.ref007","article-title":"Computational methods to identify bimodal gene expression and facilitate personalized treatment in cancer patients","volume":"1","author":"L Moody","year":"2019","journal-title":"Journal of Biomedical Informatics: X"},{"issue":"18","key":"pcbi.1010109.ref008","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/bioinformatics\/btl174","article-title":"PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer","volume":"22","author":"AE Teschendorff","year":"2006","journal-title":"Bioinformatics"},{"key":"pcbi.1010109.ref009","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4137\/CIN.S2846","article-title":"The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data","volume":"7","author":"J Wang","year":"2009","journal-title":"Cancer informatics"},{"issue":"5","key":"pcbi.1010109.ref010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/bioinformatics\/bts713","article-title":"SIBER: systematic identification of bimodally expressed genes using RNAseq data","volume":"29","author":"P Tong","year":"2013","journal-title":"Bioinformatics"},{"issue":"5","key":"pcbi.1010109.ref011","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/bioinformatics\/btt599","article-title":"A probabilistic approach to explore human miRNA targetome by integrating miRNA-overexpression data and sequence information","volume":"30","author":"Y Li","year":"2014","journal-title":"Bioinformatics"},{"issue":"5","key":"pcbi.1010109.ref012","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/gene.2012.12","article-title":"The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease","volume":"13","author":"CT Watson","year":"2012","journal-title":"Genes Immun"},{"issue":"6","key":"pcbi.1010109.ref013","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1074\/jbc.273.6.3517","article-title":"Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion","volume":"273","author":"S Xu","year":"1998","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"pcbi.1010109.ref014","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1042\/bj20020903","article-title":"Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes","volume":"368","author":"I Hers","year":"2002","journal-title":"Biochem J"},{"issue":"Pt 2","key":"pcbi.1010109.ref015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1042\/BJ20041531","article-title":"Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes","volume":"388","author":"I Hers","year":"2005","journal-title":"Biochem J"},{"issue":"2","key":"pcbi.1010109.ref016","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2004.02.082","article-title":"Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation","volume":"316","author":"CJ Carlson","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"pcbi.1010109.ref017","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"KE O\u2019Reilly","year":"2006","journal-title":"Cancer Res"},{"issue":"13","key":"pcbi.1010109.ref018","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.96.13.7421","article-title":"Protein kinase B\/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1","volume":"96","author":"WH Biggs","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"pcbi.1010109.ref019","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jmoldx.2012.01.007","article-title":"Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival","volume":"14","author":"DN Kernagis","year":"2012","journal-title":"J Mol Diagn"},{"issue":"12","key":"pcbi.1010109.ref020","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1016\/j.celrep.2018.06.032","article-title":"The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma","volume":"23","author":"CJ Ricketts","year":"2018","journal-title":"Cell Rep"},{"issue":"8","key":"pcbi.1010109.ref021","doi-asserted-by":"crossref","first-page":"e1006239","DOI":"10.1371\/journal.pgen.1006239","article-title":"Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers","volume":"12","author":"SK Yoo","year":"2016","journal-title":"PLoS Genet"},{"issue":"15","key":"pcbi.1010109.ref022","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-07-4372","article-title":"Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis","volume":"14","author":"G Oler","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"10","key":"pcbi.1010109.ref023","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.bjc.6605340","article-title":"Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas","volume":"101","author":"JM Pita","year":"2009","journal-title":"Br J Cancer"},{"issue":"17","key":"pcbi.1010109.ref024","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2004.08.127","article-title":"Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes","volume":"22","author":"MA Aldred","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"pcbi.1010109.ref025","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/modpathol.2015.44","article-title":"MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors","volume":"28","author":"V Mancikova","year":"2015","journal-title":"Mod Pathol"},{"issue":"26","key":"pcbi.1010109.ref026","doi-asserted-by":"crossref","first-page":"15044","DOI":"10.1073\/pnas.251547398","article-title":"Gene expression in papillary thyroid carcinoma reveals highly consistent profiles","volume":"98","author":"Y Huang","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"pcbi.1010109.ref027","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types","volume":"26","author":"G Monaco","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"pcbi.1010109.ref028","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer","volume":"173","author":"KA Hoadley","year":"2018","journal-title":"Cell"},{"issue":"7418","key":"pcbi.1010109.ref029","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"N. Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"issue":"6797","key":"pcbi.1010109.ref030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"issue":"18","key":"pcbi.1010109.ref031","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"C Sotiriou","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"13","key":"pcbi.1010109.ref032","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-07-0533","article-title":"MicroRNA expression profiling in prostate cancer","volume":"67","author":"KP Porkka","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"pcbi.1010109.ref033","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1172\/JCI20032","article-title":"Gene expression profiling predicts clinical outcome of prostate cancer","volume":"113","author":"GV Glinsky","year":"2004","journal-title":"J Clin Invest"},{"issue":"3","key":"pcbi.1010109.ref034","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.0304146101","article-title":"Gene expression profiling identifies clinically relevant subtypes of prostate cancer","volume":"101","author":"J Lapointe","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"52","key":"pcbi.1010109.ref035","doi-asserted-by":"crossref","first-page":"21276","DOI":"10.1073\/pnas.1117029108","article-title":"Molecular classification of prostate cancer using curated expression signatures","volume":"108","author":"EK Markert","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"21","key":"pcbi.1010109.ref036","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/onc.2014.216","article-title":"Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects","volume":"34","author":"E Martinez","year":"2015","journal-title":"Oncogene"},{"issue":"Suppl 7","key":"pcbi.1010109.ref037","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2164-16-S7-S5","article-title":"Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis","volume":"16","author":"J Wang","year":"2015","journal-title":"Bmc Genomics"},{"issue":"1","key":"pcbi.1010109.ref038","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41467-018-08054-4","article-title":"Shared heritability and functional enrichment across six solid cancers","volume":"10","author":"X Jiang","year":"2019","journal-title":"Nat Commun"},{"key":"pcbi.1010109.ref039","article-title":"Survey of miRNA-miRNA cooperative regulation principles across cancer types","author":"T Shao","year":"2018","journal-title":"Brief Bioinform"},{"issue":"2","key":"pcbi.1010109.ref040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"JP Thiery","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"pcbi.1010109.ref041","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-223","article-title":"SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation","volume":"11","author":"T Acun","year":"2011","journal-title":"Bmc Cancer"},{"issue":"3","key":"pcbi.1010109.ref042","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbrc.2012.12.034","article-title":"DNA methylation is associated with transcription of Snail and Slug genes","volume":"430","author":"Y Chen","year":"2013","journal-title":"Biochem Bioph Res Co"},{"issue":"2","key":"pcbi.1010109.ref043","doi-asserted-by":"crossref","first-page":"874","DOI":"10.18632\/oncotarget.2716","article-title":"TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer","volume":"6","author":"JA Galvan","year":"2015","journal-title":"Oncotarget"},{"issue":"21","key":"pcbi.1010109.ref044","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1093\/nar\/gkr658","article-title":"Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context","volume":"39","author":"J Espada","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1010109.ref045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cam4.347","article-title":"deltaEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells","volume":"4","author":"A Fukagawa","year":"2015","journal-title":"Cancer Med"},{"issue":"6","key":"pcbi.1010109.ref046","first-page":"212840.e1","article-title":"Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter","volume":"135","author":"SO Lim","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"pcbi.1010109.ref047","article-title":"Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States","volume":"7","author":"D Jia","year":"2018","journal-title":"Cells"},{"issue":"7","key":"pcbi.1010109.ref048","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-16-2074","article-title":"Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation","volume":"77","author":"L Yu","year":"2017","journal-title":"Cancer Res"},{"issue":"4","key":"pcbi.1010109.ref049","doi-asserted-by":"crossref","first-page":"e34150","DOI":"10.1371\/journal.pone.0034150","article-title":"Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing","volume":"7","author":"J Hamfjord","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"pcbi.1010109.ref050","article-title":"Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1","volume":"19","author":"YL Hsu","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pcbi.1010109.ref051","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13058-017-0918-2","article-title":"miR-105\/93-3p promotes chemoresistance and circulating miR-105\/93-3p acts as a diagnostic biomarker for triple negative breast cancer","volume":"19","author":"HY Li","year":"2017","journal-title":"Breast Cancer Res"},{"key":"pcbi.1010109.ref052","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fgene.2018.00174","article-title":"Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4\/6 and PIK3CA Inhibitors","volume":"9","author":"F Baldassari","year":"2018","journal-title":"Front Genet"},{"issue":"12","key":"pcbi.1010109.ref053","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/s41419-017-0048-x","article-title":"MicroRNA-105 is involved in TNF-alpha-related tumor microenvironment enhanced colorectal cancer progression","volume":"8","author":"Z Shen","year":"2017","journal-title":"Cell Death Dis"},{"key":"pcbi.1010109.ref054","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.gene.2017.10.055","article-title":"MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression","volume":"641","author":"K Zhang","year":"2018","journal-title":"Gene"},{"key":"pcbi.1010109.ref055","article-title":"MicroRNA-105 promotes epithelial-mesenchymal transition of nonsmall lung cancer cells through upregulating Mcl-1","author":"X Jin","year":"2018","journal-title":"J Cell Biochem"},{"issue":"8","key":"pcbi.1010109.ref056","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4161\/epi.29628","article-title":"A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors","volume":"9","author":"A Loriot","year":"2014","journal-title":"Epigenetics"},{"issue":"5","key":"pcbi.1010109.ref057","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","article-title":"Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells","volume":"20","author":"W Yan","year":"2018","journal-title":"Nature cell biology"},{"issue":"4","key":"pcbi.1010109.ref058","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","article-title":"Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis","volume":"25","author":"W Zhou","year":"2014","journal-title":"Cancer cell"},{"key":"pcbi.1010109.ref059","doi-asserted-by":"crossref","first-page":"e4674","DOI":"10.7717\/peerj.4674","article-title":"Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer","volume":"6","author":"J Tang","year":"2018","journal-title":"PeerJ"},{"issue":"6","key":"pcbi.1010109.ref060","first-page":"7842","article-title":"Reduced miR-105-1 levels are associated with poor survival of patients with non-small cell lung cancer","volume":"14","author":"G Lu","year":"2017","journal-title":"Oncol Lett"},{"issue":"7","key":"pcbi.1010109.ref061","first-page":"10855","article-title":"Identification of low miR-105 expression as a novel poor prognostic predictor for human glioma","volume":"8","author":"Y Guan","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"24","key":"pcbi.1010109.ref062","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.18632\/oncotarget.2679","article-title":"MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis","volume":"5","author":"W Yan","year":"2014","journal-title":"Oncotarget"},{"issue":"7","key":"pcbi.1010109.ref063","doi-asserted-by":"crossref","first-page":"11896","DOI":"10.18632\/oncotarget.14435","article-title":"High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1","volume":"8","author":"YS Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"pcbi.1010109.ref064","doi-asserted-by":"crossref","first-page":"1010428317705766","DOI":"10.1177\/1010428317705766","article-title":"MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12","volume":"39","author":"J Zhang","year":"2017","journal-title":"Tumour Biol"},{"issue":"23","key":"pcbi.1010109.ref065","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1002\/1873-3468.12458","article-title":"MicroRNA-105 targets SOX9 and inhibits human glioma cell progression","volume":"590","author":"X Liu","year":"2016","journal-title":"FEBS letters"},{"issue":"8","key":"pcbi.1010109.ref066","doi-asserted-by":"crossref","first-page":"e70515","DOI":"10.1371\/journal.pone.0070515","article-title":"miR-105 inhibits prostate tumour growth by suppressing CDK6 levels","volume":"8","author":"DR Honeywell","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"pcbi.1010109.ref067","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cellsig.2009.01.004","article-title":"Akt-dependent and -independent mechanisms of mTOR regulation in cancer","volume":"21","author":"RM Memmott","year":"2009","journal-title":"Cell Signal"},{"issue":"12","key":"pcbi.1010109.ref068","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/ijc.24748","article-title":"Akt-mediated regulation of NF kappa B and the essentialness of NF kappa B for the oncogenicity of PI3K and Akt","volume":"125","author":"D Bai","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"pcbi.1010109.ref069","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"A Brunet","year":"1999","journal-title":"Cell"},{"issue":"1","key":"pcbi.1010109.ref070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"S Chandarlapaty","year":"2011","journal-title":"Cancer cell"},{"issue":"7254","key":"pcbi.1010109.ref071","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature08170","article-title":"Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps","volume":"460","author":"SW Chi","year":"2009","journal-title":"Nature"},{"issue":"21","key":"pcbi.1010109.ref072","doi-asserted-by":"crossref","first-page":"11153","DOI":"10.1093\/nar\/gky917","article-title":"CLIPick: a sensitive peak caller for expression-based deconvolution of HITS-CLIP signals","volume":"46","author":"S Park","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"pcbi.1010109.ref073","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1093\/carcin\/bgu208","article-title":"MicroRNA-105 suppresses cell proliferation and inhibits PI3K\/AKT signaling in human hepatocellular carcinoma","volume":"35","author":"G Shen","year":"2014","journal-title":"Carcinogenesis"},{"issue":"3","key":"pcbi.1010109.ref074","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clbc.2014.12.007","article-title":"High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer","volume":"15","author":"A Nishimukai","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"pcbi.1010109.ref075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12916-015-0496-z","article-title":"Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer","volume":"13","author":"KD Yu","year":"2015","journal-title":"BMC medicine"},{"key":"pcbi.1010109.ref076","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"V Agarwal","year":"2015","journal-title":"Elife"},{"issue":"1","key":"pcbi.1010109.ref077","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"DW Huang","year":"2009","journal-title":"Nat Protoc"},{"issue":"7391","key":"pcbi.1010109.ref078","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"issue":"Database issue","key":"pcbi.1010109.ref079","first-page":"D955","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pcbi.1010109.ref080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbagrm.2018.12.009","article-title":"Epigenetic regulation of carnitine palmitoyltransferase 1 (Cpt1a) by high fat diet","volume":"1862","author":"L Moody","year":"2019","journal-title":"Biochim Biophys Acta Gene Regul Mech"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1010109","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T16:16:31Z","timestamp":1654877791000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010109"}},"subtitle":[],"editor":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":80,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1010109","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}